All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervical Neoplasms-15572004
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 15572004 A107G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
2 15572004 A171G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
3 15572004 A200G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
4 15572004 A276G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
5 15572004 A334G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
6 15572004 A350G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
7 15572004 A356G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
8 15572004 A36G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
9 15572004 A64G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
10 15572004 A95G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
11 15572004 C183G
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
12 15572004 C32Y
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
13 15572004 K36R
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
14 15572004 K67R
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
15 15572004 N22D
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
16 15572004 R11K
E6
E6
Uterine Cervical Neoplasms
G
R
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.